Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT02661178 Completed - Healthy Volunteers Clinical Trials

First in Man Clinical Trial of Emodepside (BAY 44-4400)

Start date: December 2015
Phase: Phase 1
Study type: Interventional

This study will investigate the safety, tolerability, and pharmacokinetics of single ascending doses of emodepside (BAY 44-4400) in healthy male volunteers. This study will also conduct an exploratory investigation of the relative bioavailability of emodepside administered as tablets and determine the effect of food on the pharmacokinetics.

NCT ID: NCT02652936 Completed - Healthy Volunteers Clinical Trials

A Pharmacokinetics Study of AF-130 in Healthy Subjects

Start date: October 2015
Phase: Phase 1
Study type: Interventional

This is a 2-part, single centre, single (Part 1) and multiple (Part 2) dose escalation study in healthy male subjects.

NCT ID: NCT02650895 Completed - Healthy Volunteers Clinical Trials

Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001)

Start date: June 2, 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of single ascending intravenous (IV) doses of efprezimod alfa in healthy adult participants.

NCT ID: NCT02647697 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers

Start date: January 2016
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetics (PK) profile of Radiprodil in suspension form in healthy adult subjects.

NCT ID: NCT02646358 Completed - Healthy Volunteers Clinical Trials

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Start date: January 2016
Phase: Phase 1
Study type: Interventional

This is an open-label study designed to evaluate the effect of renal disease on the pharmacokinetics of vepoloxamer relative to the pharmacokinetics in healthy subjects with normal renal function.

NCT ID: NCT02641353 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension

Start date: January 5, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess how much of apremilast is found in the blood unchanged when administered as an oral suspension compared to when it is administered as a tablet formulation. The effect of food on apremilast oral suspension will also be evaluated. In addition, information on the safety and tolerability of apremilast will be obtained.

NCT ID: NCT02637284 Active, not recruiting - Healthy Volunteers Clinical Trials

PCO-02 - Safety and Pharmacokinetics Trial

Start date: October 2015
Phase: Phase 1
Study type: Interventional

Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.

NCT ID: NCT02635594 Completed - Healthy Volunteers Clinical Trials

Effects of Carnipure® Tartrate on Postprandial Endothelial Function and Recovery

Start date: December 2015
Phase: N/A
Study type: Interventional

Investigation of 4 weeks supplementation with Carnipure® tartrate on endothelial function and parameters of recovery after physical exertion.

NCT ID: NCT02633696 Completed - Healthy Volunteers Clinical Trials

Study to Investigate the Absolute Bioavailability of Oral Sylibin

Start date: October 2013
Phase: Phase 1
Study type: Interventional

This clinical trial phase I in healthy volunteers is intended to describe the oral bioavailability of the silybin-phosphatidylcholine complex by calculating the area under the curve (AUC0-? and AUC0-12) after administration of the same dose of oral silybin (AUCo) and intravenous silybin (AUC iv).

NCT ID: NCT02632331 Completed - Healthy Volunteers Clinical Trials

ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825

Start date: January 2009
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the effect of food on the pharmacokinetics and safety after administration of ASP8825 in healthy non-elderly adult male subjects.